Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Sorafenib_MK.2206

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Sorafenib_MK.2206 BRAF, KDR, FLT4, PDGFRB, KIT, FLT3, RET and AKT1/2/3 Drug combination Selleck Chemicals S1040, S1078

Cell Line (34)
Cell LineAUCGI50
JHH50.630.425
B10.680.5
JHH70.741.312
JHH10.741.633
HCC.1.10.772.844
Huh10.772.132
HCC.30.771.45
Huh70.792.8
HCC.1.20.792.4
HLE0.813.9
SNU3680.814.832
SNU1820.812.368
JHH60.823.55
MHCC97H0.853.076
PLC.PRF50.854.9


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it